(JAZZ) Jazz Pharmaceuticals Renko charts technical analysis
(JAZZ) Jazz Pharmaceuticals Renko charts technical analysis Renko analysis of Jazz Pharmaceuticals | Buy/Sell Jazz Pharmaceuticals
Jazz Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Jazz Pharmaceuticals is 895970
Date | Closing Price | Open | High | Low | Volume |
20 Wed Nov 2024 | 119.24 | 116.43 | 119.47 | 116.19 | 0.407 Mn |
19 Tue Nov 2024 | 116.82 | 117.23 | 118.49 | 115.65 | 0.644 Mn |
18 Mon Nov 2024 | 117.59 | 122.08 | 122.88 | 117.46 | 0.647 Mn |
15 Fri Nov 2024 | 121.65 | 122.31 | 123.19 | 120.41 | 0.718 Mn |
14 Thu Nov 2024 | 124.27 | 127.00 | 127.00 | 123.77 | 0.914 Mn |
13 Wed Nov 2024 | 127.65 | 128.08 | 128.99 | 127.14 | 0.812 Mn |
12 Tue Nov 2024 | 127.74 | 126.11 | 128.37 | 126.00 | 1.035 Mn |
11 Mon Nov 2024 | 127.12 | 124.50 | 127.36 | 123.12 | 1.001 Mn |
08 Fri Nov 2024 | 123.61 | 118.52 | 123.97 | 118.06 | 0.868 Mn |
07 Thu Nov 2024 | 119.08 | 116.86 | 121.24 | 115.77 | 1.499 Mn |
Indicators analysis of Jazz Pharmaceuticals (JAZZ)
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Jazz Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Jazz Pharmaceuticals in short term but the sell signal is initial and weak.
Jazz Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Jazz Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Jazz Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 122.84 and Jazz Pharmaceuticals (JAZZ) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Jazz Pharmaceuticals (JAZZ) stock. Volume based technical analysis of Jazz Pharmaceuticals (JAZZ) stock is negative.
Jazz Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Renko charts
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Jazz Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Jazz Pharmaceuticals in short term but the sell signal is initial and weak.
Jazz Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Jazz Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Jazz Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 122.84 and Jazz Pharmaceuticals (JAZZ) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Jazz Pharmaceuticals (JAZZ) stock. Volume based technical analysis of Jazz Pharmaceuticals (JAZZ) stock is negative.
Jazz Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.